Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
Right From The Start: Smarter Developability For Stronger Formulations
Early developability assessment integrates manufacturability, QbD, flexible formulations, and CDMO support to cut risk, speed development, and enable scalable, robust drugs.
-
NGS In GMP Manufacturing: Reducing Risk, Increasing Return
Global regulators now recognize NGS as a rigorous, GMP‑ready tool for viral safety, driving a shift toward scalable quality strategies. Learn why NGS is becoming central to modern manufacturing.
-
Selecting A CDMO For Custom Activated PEGs
Custom-activated PEGs require thoughtful planning and precise analytical control. Discover key considerations for selecting a partner capable of supporting scalable, compliant PEGylation.
-
Assessing Developability And Designing Advanceable Formulations From The Start
Discover how early developability assessments and a quality-by-design approach can streamline formulation, reduce risk, and accelerate your path to successful, cost-effective drug development.
-
Navigating Emerging Therapeutics: Cannabinoid And Psilocybin Drug Development
Cannabinoid and psilocybin therapies are advancing rapidly, and Mikart supports innovators with DEA-licensed facilities, formulation expertise, regulatory guidance, and manufacturing capabilities from clinical development to commercialization.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
Development Of A Non-Standard Protein Therapeutic
Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.
-
MicroCoat™ Technology DFor Taste-Masking Amodiaquine, Artesunate In Oral Antimalarial Formulations
Drive forward the development and adoption of taste‑masked ASAQ micropellets so children in low‑resource settings can receive life‑saving antimalarial treatment that is both effective and easy to take.
-
Using DSC And MDSC To Study Material Interactions Of APIs And Excipients
Thermal analysis reveals how particle size and morphology influence material interactions and stability. Learn how DSC and MDSC techniques uncover compatibility issues and guide better excipient selection.
-
Remote Measurements For Bulk Samples
Remote Raman spectroscopy enables accurate material identification at long distances without complex focusing. Learn how pathlength, sample properties, and substrate choice impact signal quality.
-
Lentiviral Vector Upstream Process
Scalable lentiviral vector production is moving beyond adherent systems. Learn how streamlined workflows enable linear scale-up in stirred-tank bioreactors for cost-effective gene therapy manufacturing.
FORMULATION DEVELOPMENT SOLUTIONS
- Granulated Materials: Easy Handling For Improved Process Efficiency
- Keep A Close Eye On Quality With Excipients For Drug Formulation
- Multiparticulates For Modified Release Systems
- Developing Palatable, Age Appropriate Drug Products
- A CDMO With Oral Solid Dose And Sterile Injectable Expertise
- Speed, Scale, And Supply With Innovative Cell Culture Solutions
- HyClone™ Peak Expression Medium
- Where Expertise Meets Simplicity: BD PartnerPath™ Program
- Develop. De-risk. Deliver.
- HyClone™ Prime Expression Medium
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- Eli Lilly To Build New $3.5B Injectable Drug Manufacturing Site Supporting GLP-1 Therapies In Pennsylvania
- Veranova Appoints Jacquelyn Martin As Chief Quality Officer
- Halo Pharma To Become A Stand-Alone Drug Product Contract Development And Manufacturing Organization (CDMO)
- Eurofins CDMO Alphora Announces Development & Implementation Of AI-Powered Salt And Co-Crystal Screening Software
- Coating Place Announces Leadership Appointments To Support Next Phase Of Growth
- Mikart Celebrates 50 Years Of Excellence In Pharmaceutical Manufacturing
- Mikart Signs Lease For New Headquarters At Cumberland Center II In Northwest Atlanta
- Genentech To Double Its Investment At North Carolina Drug Manufacturing Facility
- CDMO Alcami Expands RTP Footprint With New Durham Facility And Major Lab Expansion
- Wilmington PharmaTech Appoints Seasoned Commercial Leader To Drive Growth